2016-03-12T00:00:00.000-05:00
Goldman Sachs,-0.500506
Piedmont Investment Advisors,0.229514
Ratings Network.com reports,-0.217179
strong buy rating,0.37115
price target,-0.500506
business’s stock,-0.293738
life-transforming therapeutic products,0.447843
Asset Management Inc.,0.271425
stock,-0.0731571
Monday,-0.500506
Alexion Pharmaceuticals Inc.,0.560435
InvestorPlace Broker Center,0.555736
biopharmaceutical company,0.29854
Alexion Pharmaceuticals,-0.0538294
sell rating,0.380077
metabolic rare disease,-0.206178
Fortaleza Asset Management,0.271425
personal trading style,0.598412
target price,-0.477413
research note,-0.500506
average price,0.223879
shares,-0.0446559
executive vice president,0.218254
concise daily summary,0.448938
Director Leonard Bell,-0.293738
stock broker,0.245696
consensus rating,0.348051
Investment Advisors LLC,0.229514
complement inhibitor portfolio,0.306346
equities research analyst,0.380077
quarter,0.0352282
